Loading...
Dolphin Pharmaceutical — Repaglinide Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #12 for Repaglinide · $1.4K export value · DGFT Verified
Dolphin Pharmaceutical is the #12 Indian exporter of Repaglinide with $1.4K in export value and 3 verified shipments. Dolphin Pharmaceutical holds a 0.0% market share in Repaglinide exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.2M | 140 | 60.5% |
| FRANCE | $1.1M | 123 | 15.8% |
| CANADA | $503.4K | 29 | 7.3% |
| VIETNAM | $272.7K | 20 | 4.0% |
| CROATIA | $246.6K | 23 | 3.6% |
| MALTA | $204.4K | 126 | 3.0% |
| NETHERLANDS | $90.4K | 57 | 1.3% |
| GREECE | $70.4K | 10 | 1.0% |
| UNITED KINGDOM | $63.2K | 2 | 0.9% |
| GERMANY | $57.1K | 5 | 0.8% |
India exports Repaglinide to 36 countries. The top destination is UNITED STATES (60.5%), followed by FRANCE and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $511.2K | 14 |
| RISING PHARMA HOLDINGS INC | UNITED STATES | $463.1K | 16 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $461.1K | 14 |
| RISING PHARMA HOLDINGS, INC. ,. | UNITED STATES | $452.3K | 14 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $400.0K | 8 |
India exported $6.9M worth of Repaglinide through 819 shipments from 41 suppliers to 36 countries, serving 112 buyers globally. Dolphin Pharmaceutical contributes $1.4K to this total, accounting for 0.0% of India's Repaglinide exports.
Dolphin Pharmaceutical's average Repaglinide shipment value is $458 per consignment, based on 3 shipments totaling $1.4K.
Dolphin Pharmaceutical ranks #12 among 41 Indian Repaglinide exporters with a 0.0% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($3.6M), AUROBINDO PHARMA LIMITED ($1.8M), USV PRIVATE LIMITED ($883.7K). Dolphin Pharmaceutical processed 3 shipments to 1 destination countries.
What Dolphin Pharmaceutical must comply with to export Repaglinide to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | GMSANJIVANI LLP | $1.7K | 15 | 2 | $115 |
| 11 | DOSHI MEDICARE PRIVATE LIMITED | $1.6K | 8 | 1 | $195 |
| 12 | DOLPHIN PHARMACEUTICAL ★ | $1.4K | 3 | 1 | $458 |
Dolphin Pharmaceutical ranks #12 among 41 Indian Repaglinide exporters. Average shipment value of $458 compared to the market average of $168.2K. The closest competitors by value are GMSANJIVANI LLP and DOSHI MEDICARE PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD (INSNF6) | 110 | 13.4% |
| HYDERABAD ICD | 95 | 11.6% |
| SAHAR AIR | 81 | 9.9% |
| HYDERABAD AIR | 54 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 51 | 6.2% |
| DELHI AIR | 48 | 5.9% |
| ICD SANATHNAGAR, HYD | 48 | 5.9% |
| DELHI AIR CARGO ACC (INDEL4) | 46 | 5.6% |
Latest developments and market context
Detailed market intelligence for Repaglinide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dolphin Pharmaceutical's Repaglinide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| UNITED STATES |
| $400.0K |
| 8 |
| RISING PHARMA HOLDINGS, INC. | UNITED STATES | $368.6K | 25 |
| ARROW GENERIQUES, | FRANCE | $341.2K | 69 |
| AUROLOGISTICS LLC | UNITED STATES | $300.0K | 6 |
| AURO PHARMA INC, | CANADA | $256.4K | 17 |
India's Repaglinide is purchased by 112 buyers worldwide. The top buyer is AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), followed by RISING PHARMA HOLDINGS INC and AUROLOGISTICS LLC(AUROBINDO PHARMA.
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 36+ countries, 112+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Dolphin Pharmaceutical.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Repaglinide. For current shipment-level data, contact TransData Nexus.